Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population

Journal of Affective Disorders

Volumn 161, Issue , 2014, Pages 73-78

  Shen, Xinhua ^a   Wu, Yanfeng ^b   Guan, Tiefeng ^a   Wang, Xiaoquan ^c   Qian, Mincai ^a   Lin, Min ^a   Shen, Zhongxia ^a   Sun, Jushui ^a   Zhong, Hua ^a   Yang, Jianhong ^a   Li, Liang ^a   Yuan, Yonggui ^d  

^a HUZHOU CENTRAL HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c The Second People's Hospital of Wuhu   (China)

^d AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Antidepressant response; Catechol O methyltransferase; Major depressive disorder; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CATECHOL METHYLTRANSFERASE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PRIMER DNA;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DSM-IV; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ADULT; ANTIDEPRESSIVE AGENTS; BASE SEQUENCE; CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898749546     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.03.008     Document Type: Article

References (27)

1. E. Aberg, A. Fandino-Losada, L.K. Sjoholm, Y. Forsell, and C. Lavebratt The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study J. Affect. Disord. 129 2011 158 166
2. O.P. Almeida, K. McCaul, G.J. Hankey, P. Norman, K. Jamrozik, and L. Flicker Homocysteine and depression in later life Arch. Gen. Psychiatry 65 2008 1286 1294
3. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, S. Melhem, B.S. Kolachana, T.M. Hyde, M.M. Herman, J. Apud, M.F. Egan, J.E. Kleinman, and D.R. Weinberger Functional analysis of genetic variation in catechol-O- methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain Am. J. Hum. Genet. 75 2004 807 821 (Pubitemid 39390488)
4. F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes Genet. Epidemiol. 25 2003 115 121 (Pubitemid 37064867)
5. A. Evinova, E. Babusikova, S. Straka, I. Ondrejka, and J. Lehotsky Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population Gen. Physiol. Biophys. 31 2012 415 422
6. A. Ezzaher, D.H. Mouhamed, A. Mechri, A. Omezzine, F. Neffati, W. Douki, A. Bouslama, L. Gaha, and M.F. Najjar Hyperhomocysteinemia in Tunisian bipolar I patients Psychiatry Clin. Neurosci. 65 2011 664 671
7. S. Grover, M. Gupta, and R. Kukreti Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics Indian J. Hum. Genet. 17 1 2011 S4 S11 (Suppl)
8. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
9. P.J. Harrison, and E.M. Tunbridge Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders Neuropsychopharmacology 33 2008 3037 3045
10. A. Hatzimanolis, S. Vitoratou, L. Mandelli, C. Vaiopoulos, F.A. Nearchou, C.N. Stefanis, A. Serretti, and N.C. Stefanis Potential role of membrane-bound COMT gene polymorphisms in female depression vulnerability J. Affect. Disord 2013 316 322
11. J.P. Houston, W. Zou, V. Aris, B. Fijal, P. Chen, A.N. Heinloth, and J. Martinez Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder Psychiatry Res. 200 2012 63 65
12. R. Jain, and W.C. Jackson Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies J. Clin. Psychiatry 73 2012 e30
13. J.M. Kim, R. Stewart, S.W. Kim, S.J. Yang, I.S. Shin, and J.S. Yoon Modification by two genes of associations between general somatic health and incident depressive syndrome in older people Psychosom. Med. 71 2009 286 291
14. N.A. Kocabas Catechol-O-methyltransferase (COMT) pharmacogenetics in the treatment response phenotypes of major depressive disorder (MDD) CNS Neurol. Disord. Drug Targets 11 2012 264 272
15. K.P. Lesch Gene-environment interaction and the genetics of depression J. Psychiatry Neurosci. 29 2004 174 184 (Pubitemid 38829854)
16. S.J. Lewis, R. Araya, S. Leary, G.D. Smith, and A. Ness Folic acid supplementation during pregnancy may protect against depression 21 months after pregnancy, an effect modified by MTHFR C677T genotype Eur. J. Clin. Nutr. 66 2012 97 103
17. S.J. Lewis, D.A. Lawlor, S.G. Davey, R. Araya, N. Timpson, I.N. Day, and S. Ebrahim The thermolabile variant of MTHFR is associated with depression in the British women's heart and health study and a meta-analysis Mol. Psychiatry 11 2006 352 360
18. M.H. Lizer, R.L. Bogdan, and R.S. Kidd Comparison of the frequency of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in depressed versus nondepressed patients J. Psychiatr. Pract. 17 2011 404 409
19. S. Lopez-Leon, A.C. Janssens, L.A. Gonzalez-Zuloeta, J. Del-Favero, S.J. Claes, B.A. Oostra, and C.M. van Duijn Meta-analyses of genetic studies on major depressive disorder Mol. Psychiatry 13 2008 772 785 (Pubitemid 352032108)
20. V.S. Mattay, T.E. Goldberg, F. Fera, A.R. Hariri, A. Tessitore, M.F. Egan, B. Kolachana, J.H. Callicott, and D.R. Weinberger Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine Proc. Natl. Acad. Sci. USA 100 2003 6186 6191 (Pubitemid 36576952)
21. D. Mischoulon, S. Lamon-Fava, J. Selhub, J. Katz, G.I. Papakostas, D.V. Iosifescu, A.S. Yeung, C.M. Dording, A.H. Farabaugh, A.J. Clain, L. Baer, J.E. Alpert, A.A. Nierenberg, and M. Fava Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment CNS Spectr. 17 2012 76 86
22. N. Naumovski, M. Veysey, X. Ng, L. Boyd, L. Dufficy, B. Blades, C. Travers, P. Lewis, J. Sturm, M. Townley-Jones, Z. Yates, P. Roach, and M. Lucock The folic acid endophenotype and depression in an elderly population J. Nutr. Health Aging 14 2010 829 833
23. A. Serretti, A. Chiesa, R. Calati, I. Massat, S. Linotte, S. Kasper, Y. Lecrubier, M. Fink, I. Antonijevic, C. Forray, L. Snyder, J. Bollen, J. Zohar, D. De Ronchi, D. Souery, and J. Mendlewicz No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression Psychiatry Res. 188 2011 166 169
24. S.J. Tsai, C.J. Hong, and Y.J. Liou Effects of BDNF polymorphisms on antidepressant action Psychiatry Investig. 7 2010 236 242
25. J. Vehof, H. Burger, B. Wilffert, H.A. Al, B.Z. Alizadeh, and H. Snieder Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes Eur. Neuropsychopharmacol. 22 2012 625 631
26. N.D. Volkow, J.S. Fowler, and G.J. Wang The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies Neuropharmacology 47 1 2004 S3 S13 (Suppl)
27. Z. Xu, Z. Zhang, Y. Shi, M. Pu, Y. Yuan, X. Zhang, and L. Li Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response J. Affect Disord. 133 2011 165 173